GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Caliber Imaging & Diagnostics Inc (OTCPK:LCDX) » Definitions » EV-to-EBIT

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) EV-to-EBIT : -0.00 (As of Apr. 29, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Caliber Imaging & Diagnostics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Caliber Imaging & Diagnostics's Enterprise Value is $0.00 Mil. Caliber Imaging & Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2014 was $-5.30 Mil. Therefore, Caliber Imaging & Diagnostics's EV-to-EBIT for today is -0.00.

The historical rank and industry rank for Caliber Imaging & Diagnostics's EV-to-EBIT or its related term are showing as below:

LCDX's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 19.9
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Caliber Imaging & Diagnostics's Enterprise Value for the quarter that ended in Mar. 2014 was $10.42 Mil. Caliber Imaging & Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2014 was $-5.30 Mil. Caliber Imaging & Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2014 was -50.85%.


Caliber Imaging & Diagnostics EV-to-EBIT Historical Data

The historical data trend for Caliber Imaging & Diagnostics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliber Imaging & Diagnostics EV-to-EBIT Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-EBIT
- - - -2.00 -3.32

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 -1.06 -1.12 -3.32 -1.82

Competitive Comparison of Caliber Imaging & Diagnostics's EV-to-EBIT

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliber Imaging & Diagnostics's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's EV-to-EBIT falls into.



Caliber Imaging & Diagnostics EV-to-EBIT Calculation

Caliber Imaging & Diagnostics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.001/-5.3
=-0.00

Caliber Imaging & Diagnostics's current Enterprise Value is $0.00 Mil.
Caliber Imaging & Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caliber Imaging & Diagnostics  (OTCPK:LCDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Caliber Imaging & Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2014 ) =EBIT / Enterprise Value (Q: Mar. 2014 )
=-5.3/10.4237905
=-50.85 %

Caliber Imaging & Diagnostics's Enterprise Value for the quarter that ended in Mar. 2014 was $10.42 Mil.
Caliber Imaging & Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caliber Imaging & Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Caliber Imaging & Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
100 Burtt Road, Suite 203, Andover, MA, USA, 01810
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.
Executives
Paul Stuka director C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
William J Shea director, 10 percent owner 11825 N PENNSYLVANIA ST, CARMEL IN 46032
Kevin M Cronin director
Richard Christopher officer: Chief Financial Officer C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
Martin Joseph Joyce officer: Chief Financial Officer 1050 HINGHAM STREET, ROCKLAND MA 02370
Matthew S Cox director 58 OAKWOOD DRIVE, CHAPEL HILL NC 27517

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Headlines